Andrew Kenneth William Powell
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Aclaris Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Aclaris Therapeutics Inc. June 1, 202365.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2024 | Aclaris Therapeutics Inc. | Option exercise | +4,660 | — | — |
| Mar 4, 2024 | Aclaris Therapeutics Inc. | Open-market purchase | +6,000 | $1.25 | $7,500 |
| Mar 1, 2024 | Aclaris Therapeutics Inc. | Open-market purchase | +8,500 | $1.23 | $10,455 |
| Jun 2, 2023 | Aclaris Therapeutics Inc. | Option exercise | +4,507 | — | — |
| Nov 8, 2022 | Aclaris Therapeutics Inc. | Gift | −4,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.